# FDA 483 - Figuerola Group, Inc. dba Figuerola Laboratories - February 28, 2023

Source: https://www.globalkeysolutions.net/records/483/figuerola-group-inc-dba-figuerola-laboratories/0f6e20af-50b0-4f96-a83a-4a5d23f0a6e5

> FDA 483 for Figuerola Group, Inc. dba Figuerola Laboratories on February 28, 2023. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Figuerola Group, Inc. dba Figuerola Laboratories
- Inspection Date: 2023-02-28
- Product Type: other
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: Figueroa Group, Inc. dba Figueroa Laboratories in Buellton, CA, was inspected by the FDA, resulting in seven observations primarily concerning inadequate quality control for dietary supplements. The firm failed to establish proper specifications for finished products and components, did not qualify suppliers, and exhibited poor sanitation practices. Additionally, deficiencies were noted in master manufacturing records and batch production records, indicating significant gaps in their manufacturing process controls.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/greg-k-keshishyan/72308798-27be-4688-ba3c-63cd84fb1677)

Company: https://www.globalkeysolutions.net/companies/figuerola-group-inc-dba-figuerola-laboratories/3b86dc01-47c7-4f76-b0c1-987e0673620e

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6